Market News

Ani Pharmaceuticals (ANIP) Shareholder Regent Investment Management Has Raised Stake by $355,200 as Shares Declined; As Mckesson (MCK) Market Value Declined, Soros Fund Management Decreased Its Stake

McKesson Corporation (NYSE:MCK) Logo

Regent Investment Management Llc increased its stake in Ani Pharmaceuticals (ANIP) by 20.22% based on its latest 2017Q4 regulatory filing with the SEC. Regent Investment Management Llc bought 5,550 shares as the company’s stock declined 8.99% with the market. The hedge fund held 33,000 shares of the health care company at the end of 2017Q4, valued at $2.13M, up from 27,450 at the end of the previous reported quarter. Regent Investment Management Llc who had been investing in Ani Pharmaceuticals for a number of months, seems to be bullish on the $706.13M market cap company. The stock increased 1.16% or $0.69 during the last trading session, reaching $60.21. About 32,202 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 18.93% since April 17, 2017 and is uptrending. It has outperformed by 7.38% the S&P500.

George Soros decreased its stake in Mckesson Corp (MCK) by 18.12% based on its latest 2017Q4 regulatory filing with the SEC. Soros Fund Management Llc sold 12,500 shares as the company’s stock declined 12.43% with the market. The hedge fund run by George Soros held 56,500 shares of the other pharmaceuticals company at the end of 2017Q4, valued at $8.81 million, down from 69,000 at the end of the previous reported quarter. Soros Fund Management Llc who had been investing in Mckesson Corp for a number of months, seems to be less bullish one the $30.51B market cap company. The stock increased 3.52% or $5.03 during the last trading session, reaching $147.88. About 3.44 million shares traded or 91.36% up from the average. McKesson Corporation (NYSE:MCK) has declined 6.57% since April 17, 2017 and is downtrending. It has underperformed by 18.12% the S&P500.

Since March 1, 2018, it had 0 insider purchases, and 7 selling transactions for $9.84 million activity. RAYNOR DANIEL sold $439,047 worth of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) on Thursday, March 15. 1,912 shares valued at $120,647 were sold by MARSHBANKS TRACY on Wednesday, March 14. $1.47M worth of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) was sold by PRZYBYL ARTHUR. Schrepfer Robert W had sold 28,652 shares worth $1.77M on Thursday, March 1.

Among 6 analysts covering ANI Pharma (NASDAQ:ANIP), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. ANI Pharma had 20 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, November 13 by Standpoint Research. The firm has “Outperform” rating by Oppenheimer given on Friday, July 31. As per Wednesday, August 9, the company rating was maintained by Canaccord Genuity. The firm has “Buy” rating by Canaccord Genuity given on Monday, October 16. The rating was upgraded by Roth Capital on Monday, September 28 to “Buy”. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) earned “Neutral” rating by TH Capital on Wednesday, February 22. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has “Hold” rating given on Tuesday, May 24 by Standpoint Research. The company was initiated on Thursday, June 23 by Raymond James. The rating was maintained by Canaccord Genuity on Wednesday, February 28 with “Buy”. The firm has “Buy” rating given on Thursday, December 7 by Canaccord Genuity.

Investors sentiment decreased to 1.09 in Q4 2017. Its down 0.60, from 1.69 in 2017Q3. It dived, as 13 investors sold ANIP shares while 43 reduced holdings. 23 funds opened positions while 38 raised stakes. 6.25 million shares or 0.89% less from 6.31 million shares in 2017Q3 were reported. Voya Ltd invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). 25 were accumulated by Shine Inv Advisory. Piermont Cap Inc has 0.13% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 6,170 shares. Consonance Capital Mngmt Lp has 0.83% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 142,978 shares. Nomura Incorporated accumulated 284,261 shares. Schwab Charles Investment Management holds 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 64,661 shares. Jane Street Gp Inc Ltd has 6,382 shares. Mason Street Advisors Limited Liability Com owns 2,331 shares. Intrust Bancshares Na stated it has 0.13% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). 16,141 were accumulated by Legal General Gp Pcl. Ativo Cap Ltd Co accumulated 29,009 shares. Violich Capital Mngmt, a California-based fund reported 4,140 shares. Driehaus Cap Mngmt Ltd Llc invested in 3,414 shares or 0.01% of the stock. 7,519 were accumulated by Credit Suisse Ag. Meeder Asset Management, Ohio-based fund reported 227 shares.

Regent Investment Management Llc, which manages about $294.77 million and $304.82 million US Long portfolio, decreased its stake in Humana Inc (NYSE:HUM) by 2,775 shares to 5,224 shares, valued at $1.30M in 2017Q4, according to the filing. It also reduced its holding in Walgreens Boots Alli by 7,663 shares in the quarter, leaving it with 80,354 shares, and cut its stake in Enbridge Inc F (NYSE:ENB).

Analysts await McKesson Corporation (NYSE:MCK) to report earnings on May, 17. They expect $3.54 EPS, up 4.42% or $0.15 from last year’s $3.39 per share. MCK’s profit will be $730.43 million for 10.44 P/E if the $3.54 EPS becomes a reality. After $3.41 actual EPS reported by McKesson Corporation for the previous quarter, Wall Street now forecasts 3.81% EPS growth.

Soros Fund Management Llc, which manages about $4.37B US Long portfolio, upped its stake in Lam Research Corp (NASDAQ:LRCX) by 158,207 shares to 269,632 shares, valued at $49.63 million in 2017Q4, according to the filing. It also increased its holding in Charter Communications Inc N by 24,300 shares in the quarter, for a total of 49,300 shares, and has risen its stake in Twitter Inc (NYSE:TWTR).

Investors sentiment decreased to 0.79 in Q4 2017. Its down 0.09, from 0.88 in 2017Q3. It fall, as 73 investors sold MCK shares while 310 reduced holdings. 79 funds opened positions while 222 raised stakes. 177.79 million shares or 1.25% less from 180.04 million shares in 2017Q3 were reported. Cubist Systematic Strategies Limited Liability Corp owns 12,454 shares or 0.1% of their US portfolio. Focused Wealth Mgmt holds 1,200 shares or 0.06% of its portfolio. Stewart Patten Co Ltd Company stated it has 0.1% in McKesson Corporation (NYSE:MCK). Janney Montgomery Scott Limited Co reported 0.04% in McKesson Corporation (NYSE:MCK). Welch Group Incorporated Limited Liability Company holds 0.03% or 1,065 shares in its portfolio. 4,794 were accumulated by Commerzbank Aktiengesellschaft Fi. 13,173 were accumulated by Laffer Investments. Ci Global Invests reported 0% in McKesson Corporation (NYSE:MCK). 105,430 were reported by Teacher Retirement Systems Of Texas. Guggenheim Lc accumulated 465,969 shares. First National Co stated it has 0.06% in McKesson Corporation (NYSE:MCK). Cetera Advisor Lc, California-based fund reported 1,873 shares. Ajo Limited Partnership invested in 0.11% or 160,964 shares. Choate Invest has invested 0.03% of its portfolio in McKesson Corporation (NYSE:MCK). Howe And Rusling Inc holds 0% of its portfolio in McKesson Corporation (NYSE:MCK) for 162 shares.

Among 22 analysts covering McKesson Corporation (NYSE:MCK), 12 have Buy rating, 1 Sell and 9 Hold. Therefore 55% are positive. McKesson Corporation had 82 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Robert W. Baird on Wednesday, January 17. The rating was upgraded by Mizuho to “Buy” on Wednesday, November 9. The firm has “Outperform” rating given on Tuesday, October 10 by Cowen & Co. Leerink Swann downgraded McKesson Corporation (NYSE:MCK) on Friday, October 28 to “Mkt Perform” rating. Mizuho downgraded it to “Neutral” rating and $147 target in Tuesday, January 3 report. Standpoint Research downgraded the shares of MCK in report on Friday, November 11 to “Hold” rating. On Tuesday, May 23 the stock rating was upgraded by JP Morgan to “Overweight”. The rating was maintained by Deutsche Bank on Tuesday, January 12 with “Buy”. The firm has “Outperform” rating by Raymond James given on Wednesday, January 6. Deutsche Bank downgraded McKesson Corporation (NYSE:MCK) on Friday, October 28 to “Hold” rating.

McKesson Corporation (NYSE:MCK) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *